DFCM
DTIL icon

Dark Forest Capital Management’s Precision BioSciences DTIL Stock Holding History

Dark Forest Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-608
Closed -$13.7K – 1130
2023
Q1 		$13.7K Buy
+608
New +$20K ﹤0.01% 1005
2022
Q4 		– Sell
-330
Closed -$13K – 1233
2022
Q3 		$13K Buy
+330
New +$15.7K ﹤0.01% 691

Other funds holding DTIL

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Dark Forest Capital Management's DTIL Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Precision BioSciences (DTIL) in Q2 2023, closing a stake of 608 shares — an estimated $13.7K sold.

Dark Forest Capital Management first reported a position in DTIL in Q3 2022 and held it in 2 quarters. The position peaked at $13.7K in Q1 2023. 77 funds tracked by Wall St. Rank hold DTIL as of Q2 2023.

  • Dark Forest Capital Management reported no remaining Precision BioSciences position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 608 Precision BioSciences shares in Q2 2023, an estimated $13.7K.
  • Dark Forest Capital Management first reported a position in Precision BioSciences in Q3 2022 and held it in 2 quarters.
  • Dark Forest Capital Management's Precision BioSciences position peaked at $13.7K in Q1 2023.
  • 77 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.